Supernus Pharmaceuticals | Attività Correnti



Current Assets Cambiamento Data
Abbott USD 23.66B 146M 2024-12
ANI Pharmaceuticals USD 527.68M 6.39M 2024-12
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Eisai JPY 761.1B 79.19B 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
Indivior 799M 65M 2024-09
Novo Nordisk 195.16B 17.66B 2024-09
Pacira USD 745.13M 55.16M 2024-12
Perrigo USD 2.48B 1.23B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
United Therapeutics USD 3.87B 126.5M 2024-12
Xeris Pharmaceuticals USD 167.66M 4.86M 2024-12



Supernus Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.